← Back to catalogue

Jay X2

FDA UDI

Class I (US FDA UDI)

by Sunrise Medical (US) LLC

Identity

Trade Name
Jay X2 FDA UDI
Generic Name
Gel-filled chair cushion FDA UDI
Device Name
The JAY X2® is a lightweight, maintenance-free, fluid wheelchair cushion with a reduced profile that is designed to provide stability and pressure relief to active clients. Using elements from the JAY Xtreme and Active cushions, the X2 combines JAY’s time-tested designs with its latest technologies. FDA UDI
Model / Reference
X2 FDA UDI
Description
The JAY X2® is a lightweight, maintenance-free, fluid wheelchair cushion with a reduced profile that is designed to provide stability and pressure relief to active clients. Using elements from the JAY Xtreme and Active cushions, the X2 combines JAY’s time-tested designs with its latest technologies. FDA UDI

Identifiers

Catalog Number
E2622 FDA UDI
Primary DI / UDI-DI
00016958056716 FDA UDI
FDA Product Code
IMP FDA UDI
GMDN Term
Gel-filled chair cushion FDA UDI

Classification

Device Class
Class I FDA UDI
Regulation Number
890.3920 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Gel-filled chair cushion

Jay X2 by Sunrise Medical (US) LLC — Class I — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Gel-filled chair cushion.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI af63b9f9-582f-4c33-97cc-ff9d8e8a3caf 34 fields · synced Jun 9, 2026